Semisolid Dosage

Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of “ointments” as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemi...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (182 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545927104498
ctrlnum (CKB)5400000000043359
(oapen)https://directory.doabooks.org/handle/20.500.12854/68985
(EXLCZ)995400000000043359
collection bib_alma
record_format marc
spelling Daniels, Rolf edt
Semisolid Dosage
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (182 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of “ointments” as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemical characterization of ointments as well as the inclusion of dermatological aspects led to a comprehensive understanding of the various interactions between the vehicle, the active ingredient and the skin. From then on, many researchers were involved in optimizing semi-solid formulations with respect to continuously changing therapeutic and patient needs. Aspects that have been dealt with were the optimization of dermato-biopharmaceutical properties and many different issues related to patient compliance, such as skin tolerance, applicability, and cosmetic appeal. Moreover, processing technology has been improved and analytical techniques were developed and refined in order to enable the improved characterization of the formulation itself as well as its interaction with the skin. This Special Issue serves to highlight and capture the contemporary progress and current research on semi-solid formulations as dermal drug delivery systems. We invite articles on all aspects of semi-solid formulations, highlighting the research currently undertaken to improve and better understand these complex drug delivery systems with respect to their formulation, processing and characterization issues.
English
Medicine bicssc
dermal drug delivery
diffusion cell
Franz diffusion
Skin-PAMPA
Strat-M® membrane
nanocarrier
nonivamide
methyl cellulose
skin penetration
substantivity
thermogel
tacrolimus formulation
nanogels
drug delivery
human excised skin
Jurkat cells
in situ hydrogel-forming powder
nitric oxide-releasing formulation
S-nitrosoglutathione (GSNO)
antibacterial
wound dressing
wound healing
dermal delivery
porcine skin
in vitro permeation
methadone
pain
in vitro
permeation
niacinamide
solvent
PAMPA
skin
curcumin
deformable liposomes
liposome surface charge
hydrogel
chitosan
wound therapy
IVRT
metronidazole
topical cream
semisolid dosage forms
sameness
FDA's SUPAC-SS guidance
acceptance criteria
positive and negative controls
discriminatory ability
Amphotericin B
Sepigel 305®
Leishmania infantum
cutaneous leishmaniasis
topical treatment
birch bark extract
oleogels
hydrogen bonding
triterpene
rheology
gel strength
eosinophilic esophagitis
budesonide
xanthan gum
guar gum
mucoadhesion
esophagus permeability
rheological characterization
pediatric medicine
compounded preparation
non-ionic emulsifiers
intercellular lipids
confocal Raman spectroscopy (CRS)
polyethylene glycol alkyl ethers
polyethylene glycol sorbitan fatty acid esters
3-03936-948-2
3-03936-949-0
Lunter, Dominique edt
Daniels, Rolf oth
Lunter, Dominique oth
language English
format eBook
author2 Lunter, Dominique
Daniels, Rolf
Lunter, Dominique
author_facet Lunter, Dominique
Daniels, Rolf
Lunter, Dominique
author2_variant r d rd
d l dl
author2_role HerausgeberIn
Sonstige
Sonstige
title Semisolid Dosage
spellingShingle Semisolid Dosage
title_full Semisolid Dosage
title_fullStr Semisolid Dosage
title_full_unstemmed Semisolid Dosage
title_auth Semisolid Dosage
title_new Semisolid Dosage
title_sort semisolid dosage
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (182 p.)
isbn 3-03936-948-2
3-03936-949-0
illustrated Not Illustrated
work_keys_str_mv AT danielsrolf semisoliddosage
AT lunterdominique semisoliddosage
status_str n
ids_txt_mv (CKB)5400000000043359
(oapen)https://directory.doabooks.org/handle/20.500.12854/68985
(EXLCZ)995400000000043359
carrierType_str_mv cr
is_hierarchy_title Semisolid Dosage
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1787548474245382144
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04855nam-a2201189z--4500</leader><controlfield tag="001">993545927104498</controlfield><controlfield tag="005">20231214132847.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043359</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68985</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043359</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Daniels, Rolf</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Semisolid Dosage</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (182 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of “ointments” as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemical characterization of ointments as well as the inclusion of dermatological aspects led to a comprehensive understanding of the various interactions between the vehicle, the active ingredient and the skin. From then on, many researchers were involved in optimizing semi-solid formulations with respect to continuously changing therapeutic and patient needs. Aspects that have been dealt with were the optimization of dermato-biopharmaceutical properties and many different issues related to patient compliance, such as skin tolerance, applicability, and cosmetic appeal. Moreover, processing technology has been improved and analytical techniques were developed and refined in order to enable the improved characterization of the formulation itself as well as its interaction with the skin. This Special Issue serves to highlight and capture the contemporary progress and current research on semi-solid formulations as dermal drug delivery systems. We invite articles on all aspects of semi-solid formulations, highlighting the research currently undertaken to improve and better understand these complex drug delivery systems with respect to their formulation, processing and characterization issues.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dermal drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diffusion cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Franz diffusion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Skin-PAMPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Strat-M® membrane</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanocarrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nonivamide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methyl cellulose</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin penetration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">substantivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thermogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tacrolimus formulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanogels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human excised skin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Jurkat cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in situ hydrogel-forming powder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nitric oxide-releasing formulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">S-nitrosoglutathione (GSNO)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound dressing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound healing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dermal delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">porcine skin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro permeation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methadone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">permeation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">niacinamide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solvent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PAMPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">curcumin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">deformable liposomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liposome surface charge</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chitosan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IVRT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metronidazole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">topical cream</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">semisolid dosage forms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sameness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FDA's SUPAC-SS guidance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acceptance criteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positive and negative controls</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">discriminatory ability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Amphotericin B</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sepigel 305®</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Leishmania infantum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cutaneous leishmaniasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">topical treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">birch bark extract</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oleogels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen bonding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triterpene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gel strength</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">eosinophilic esophagitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">budesonide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">xanthan gum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guar gum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucoadhesion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">esophagus permeability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheological characterization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pediatric medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">compounded preparation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-ionic emulsifiers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intercellular lipids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">confocal Raman spectroscopy (CRS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyethylene glycol alkyl ethers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyethylene glycol sorbitan fatty acid esters</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-948-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-949-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lunter, Dominique</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Daniels, Rolf</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lunter, Dominique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:34:26 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338090690004498&amp;Force_direct=true</subfield><subfield code="Z">5338090690004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338090690004498</subfield></datafield></record></collection>